Загрузка...
AXL Is a Potential Target for the Treatment of Intestinal Fibrosis
BACKGROUND: Fibrosis is the final common pathway to intestinal failure in Crohn’s disease, but no medical therapies exist to treat intestinal fibrosis. Activated myofibroblasts are key effector cells of fibrosis in multiple organ systems, including the intestine. AXL is a receptor tyrosine kinase th...
Сохранить в:
| Опубликовано в: : | Inflamm Bowel Dis |
|---|---|
| Главные авторы: | , , , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Oxford University Press
2020
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7885333/ https://ncbi.nlm.nih.gov/pubmed/32676663 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ibd/izaa169 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|